NASDAQ:CTCX Carmell (CTCX) Stock Price, News & Analysis $0.75 +0.05 (+6.80%) (As of 10:19 AM ET) Add Compare Share Share Today's Range$0.75▼$0.7550-Day Range$0.70▼$2.0052-Week Range$0.69▼$5.27Volume1,011 shsAverage Volume12,842 shsMarket Capitalization$15.55 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Carmell alerts: Email Address Carmell MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.38% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.12Based on 3 Articles This WeekInsider TradingAcquiring Shares$34,103 Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.04 out of 5 starsMedical Sector803rd out of 924 stocksSurgical & Medical Instruments Industry88th out of 97 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Carmell.Read more about Carmell's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.38% of the float of Carmell has been sold short.Short Interest Ratio / Days to CoverCarmell has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Carmell has recently increased by 40.00%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldCarmell does not currently pay a dividend.Dividend GrowthCarmell does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CTCX. Previous Next 2.8 News and Social Media Coverage News SentimentCarmell has a news sentiment score of 1.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Carmell this week, compared to 0 articles on an average week. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Carmell insiders have bought more of their company's stock than they have sold. Specifically, they have bought $34,103.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders29.00% of the stock of Carmell is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 24.22% of the stock of Carmell is held by institutions.Read more about Carmell's insider trading history. Previous Next 0.6 Earnings and Valuation Price to Book Value per Share RatioCarmell has a P/B Ratio of 0.70. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Carmell's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad DTIAir Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could become crucial to the operations of the US Military. And right now there are plans for this stock to undertake a major test project at a US Air Force based in Alaska. Now, this incredible breakthrough is still in its earliest stages… Which means you still have a chance to get in while its trading for under $10.You need to check out the full story right here. About Carmell Stock (NASDAQ:CTCX)Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023. Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.Read More CTCX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CTCX Stock News HeadlinesAugust 17, 2024 | americanbankingnews.comCarmell Co. (NASDAQ:CTCX) Short Interest Up 40.0% in JulyJuly 31, 2024 | investing.comCarmell Corporation names Kendra Bracken-Ferguson as new CEOAugust 22, 2024 | DTI (Ad)Air Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could become crucial to the operations of the US Military. And right now there are plans for this stock to undertake a major test project at a US Air Force based in Alaska. Now, this incredible breakthrough is still in its earliest stages… Which means you still have a chance to get in while its trading for under $10.July 29, 2024 | globenewswire.comCarmell Corporation Appoints New CEO Following Addition to the Russell Microcap IndexMay 25, 2024 | finance.yahoo.comCarmell Corporation (CTCX)May 16, 2024 | investorplace.comCTCX Stock Earnings: Carmell Therapeutics Reported Results for Q4 2023May 16, 2024 | investorplace.comCTCX Stock Earnings: Carmell Therapeutics Reported Results for Q1 2024April 11, 2024 | globenewswire.comCarmell Announces Successful Closing of $3.0 Million Private PlacementAugust 22, 2024 | DTI (Ad)Air Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could become crucial to the operations of the US Military. And right now there are plans for this stock to undertake a major test project at a US Air Force based in Alaska. Now, this incredible breakthrough is still in its earliest stages… Which means you still have a chance to get in while its trading for under $10.April 4, 2024 | globenewswire.comCarmell Announces $3.0 Million Private PlacementMarch 27, 2024 | globenewswire.comCarmell Announces Successful Closing of Axolotl Biologix Sale TransactionMarch 22, 2024 | investing.comCarmell Corporation divests subsidiary to focus on skincareMarch 20, 2024 | globenewswire.comCarmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix SubsidiaryMarch 18, 2024 | globenewswire.comCarmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics FieldFebruary 28, 2024 | morningstar.comCarmell Corp Ordinary Shares - Class AFebruary 26, 2024 | msn.comWhy Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day SessionFebruary 26, 2024 | globenewswire.comCarmell Announces Product Development Completed for G.L.E.E. Launch in March 2024January 6, 2024 | nasdaq.comCarmell Corporation Common Stock (CTCX)See More Headlines Receive CTCX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Carmell and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today8/22/2024Next Earnings (Estimated)11/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:CTCX CUSIPN/A CIK1842939 Webwww.carmellrx.com Phone412-894-8248FaxN/AEmployees14Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-15,440,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-171.27% Return on Assets-22.94% Debt Debt-to-Equity RatioN/A Current Ratio0.75 Quick Ratio0.75 Sales & Book Value Annual Sales$12,320.00 Price / Sales1,262.36 Cash FlowN/A Price / Cash FlowN/A Book Value$1.07 per share Price / Book0.70Miscellaneous Outstanding Shares20,803,000Free Float14,770,000Market Cap$15.55 million OptionableNot Optionable Beta0.40 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Rajiv Sarman Shukla (Age 49)Executive Chairman & CEO Comp: $292.19kMr. Bryan J. Cassaday (Age 55)Chief Financial Officer Comp: $261.7kDr. Phil Campbell Ph.D.Founder and Chief Scientific OfficerDr. Lee Weiss Ph.D.FounderDr. James Burgess M.D.FounderKey CompetitorsTELA BioNASDAQ:TELAHyperfineNASDAQ:HYPRMilestone ScientificNYSE:MLSSInspireMDNYSE:NSPRVivani MedicalNASDAQ:VANIView All CompetitorsInsiders & InstitutionsRichard A UptonBought 3,600 shares on 8/20/2024Total: $3,204.00 ($0.89/share)Warberg Asset Management LLCBought 45,000 shares on 8/9/2024Ownership: 0.216%Richard A UptonBought 2,000 shares on 6/12/2024Total: $4,400.00 ($2.20/share)Bryan J CassadayBought 440 shares on 6/10/2024Total: $1,100.00 ($2.50/share)Rajiv ShuklaBought 2,100 shares on 6/6/2024Total: $5,523.00 ($2.63/share)View All Insider TransactionsView All Institutional Transactions CTCX Stock Analysis - Frequently Asked Questions How have CTCX shares performed this year? Carmell's stock was trading at $3.81 at the start of the year. Since then, CTCX stock has decreased by 80.4% and is now trading at $0.7476. View the best growth stocks for 2024 here. Who are Carmell's major shareholders? Carmell's top institutional shareholders include Warberg Asset Management LLC (0.22%). Insiders that own company stock include Rajiv Shukla, Richard A Upton, Gilles Spenlehauer, Bryan J Cassaday, Randolph W Hubbell and Scott M Frisch. View institutional ownership trends. How do I buy shares of Carmell? Shares of CTCX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CTCX) was last updated on 8/22/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredAir Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could becom...DTI | SponsoredTrump is sounding the alarmEurope is one of the latest to release a central bank digital currency and along with it, new cash rules. Chri...Preserve Gold | SponsoredUS developing “superweapon” to defeat China and Russia?Our new superweapon is a gift to every patriot. I predict the devastating new tech behind this weapon will cre...Paradigm Press | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredAmazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | Sponsored625,000% GainThe recent crypto pullback has been brutal, causing widespread panic among investors. But for us, it’s just an...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carmell Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carmell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
